Arbutus Biopharma Corporation ABUS Short-Term Investments
Short-Term Investments at other companies
Other financials
Where this comes from
Reported directly by Arbutus Biopharma Corporation in its filing.
Tagged under the XBRL concept us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent.
The official record: Arbutus Biopharma Corporation’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Arbutus Biopharma Corporation's short-term investments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Arbutus Biopharma Corporation's short-term investments?
- Arbutus Biopharma Corporation (ABUS) reported short-term investments of $71.52M in Q1 2026.
- How has Arbutus Biopharma Corporation's short-term investments changed year-over-year?
- Arbutus Biopharma Corporation's short-term investments decreased by 5.4% year-over-year, from $75.63M to $71.52M.
- What is the long-term trend for Arbutus Biopharma Corporation's short-term investments?
- Over 5 years (2020 to 2025), Arbutus Biopharma Corporation's short-term investments has grown at a 0.7% compound annual growth rate (CAGR), from $71.02M to $73.46M.
- What does short-term investments mean?
- Marketable securities and other investments with maturities between three months and one year, providing yield above cash while maintaining liquidity.